Feb
01
2023
Following in Lilly’s footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3 – FiercePharma
Following in Lilly’s footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3 FiercePharma